February 15, 2019

1:00-1:30 pmScientific Progress in LeukemiaRichard Larson, MD
1:30-2:00 pmMyelodysplastic Syndrome and Myeloproliferative NeoplasmsToyosi Odenike, MD
2:00-2:30 pmBREAK
2:30-3:00 pmPractice Changing and Promising New Treatments in Multiple MyelomaAndrzej Jakubowiak, MD, PhD
3:00-3:30 pmAdvances in Cellular TherapyPeter Riedell, MD
3:30-4:00 pmBREAK
4:00-4:30 pmEvolving Standards of Care in LymphomaSonali Smith, MD
4:30-5:00 pmClinical Updates in Clotting DisordersKenneth Cohen, MD
5:00-5:45 pmCAR T Cell Therapy in Non-Hodgkin LymphomaStephen Schuster, MD
5:45-6:00 pmClose

Faculty Disclosure


As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with anycommercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity. Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.